Recombinant 2019-nCoV Nucleocapsid Protein V2
Recombinant 2019-nCoV Nucleocapsid Protein V2 from ELK Biotechnology Read more ›
Product Description
Recombinant 2019-nCoV Nucleocapsid Protein V2 is an ELK Biotechnology recombinant protein for research use.
Description
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 is expressed with a 6His tag at the N-terminus.
Background
Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
Handling information
| Delivery condition | The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below. |
|---|
Key Facts
| Target | Recombinant 2019-nCoV Nucleocapsid Protein V2 |
| Also known as | 2019-nCoV coronavirus NP Protein; 2019-nCoV np Protein; 2019-nCoV novel coronavirus Nucleoprotein Protein |
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized protein |
| Research area | Infectious Diseases, Molecular Biology |
| Specification | PURITY | ENDOTOXIN | BIOACTIVITY |
|---|---|---|---|
| Product QC |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Not intended for diagnostic or therapeutic use.